Pollak M R MR - OmicsDI

Show results for

Unknown (60)
Metabolomics (4)

Repository

MetaboLights (4)

Technology Type

Mass spectrometry (4)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Biological experiment negative - Orbitrap velos CID (Thermo Scientific) (1)
Biological experiment negative - QTRAP 4000 (AB Sciex) (1)
Biological experiment positive - Orbitrap velos CID (Thermo Scientific) (1)
Biological experiment positive - QTRAP 4000 (AB Sciex) (1)
Control experiment 1 negative - Orbitrap velos CID (Thermo Scientific) (1)
Control experiment 1 positive - Orbitrap velos CID (Thermo Scientific) (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Orbitrap elite negative (Thermo Scientific) (1)
Orbitrap elite positive (Thermo Scientific) (1)
Orbitrap velos CID negative (Thermo Scientific) (1)
Orbitrap velos CID positive (Thermo Scientific) (1)
Orbitrap velos HCD negative (Thermo Scientific) (1)
Orbitrap velos HCD positive (Thermo Scientific) (1)
QExactive negative (Thermo Scientific) (1)
QExactive positive (Thermo Scientific) (1)
QTOF G6550A negative (Agilent) (1)
QTOF G6550A positive (Agilent) (1)
QTRAP 4000 negative (AB Sciex) (1)
QTRAP 4000 positive (AB Sciex) (1)
QTRAP 6500 negative (AB Sciex) (1)
QTRAP 6500 positive (AB Sciex) (1)

Publication Date

2021 (2)
2017 (2)

CHEBI ID

CHEBI:16870 (2)
CHEBI:73024 (2)
CHEBI:132673 (1)
CHEBI:132676 (1)
CHEBI:132957 (1)
CHEBI:134270 (1)
CHEBI:134271 (1)
CHEBI:134428 (1)
CHEBI:134451 (1)
CHEBI:136186 (1)
CHEBI:136203 (1)
CHEBI:136236 (1)
CHEBI:136239 (1)
CHEBI:136243 (1)
CHEBI:136256 (1)
CHEBI:136259 (1)
CHEBI:136579 (1)
CHEBI:137597 (1)
CHEBI:140362 (1)
CHEBI:141588 (1)
CHEBI:141589 (1)
CHEBI:141590 (1)
CHEBI:142699 (1)
CHEBI:155834 (1)
CHEBI:155835 (1)
CHEBI:15603 (1)
CHEBI:15676 (1)
CHEBI:15698 (1)
CHEBI:15891 (1)
CHEBI:16010 (1)

Metabolite Name

-|-|-|-|-|-|-|-|-|-|-|-|-|-|PC 16:0/22:5 (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|-|PC 20:2_16:0 (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|-|PC 20:3_18:2 (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|-|PG 22:5_18:2 (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|-|SM 25:1 (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|P-PE P-18:0/20:3|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|P-PE P-18:1/22:5|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|P-PE P-30:0/10:6|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|PC 18:1_17:1|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|PE 20:4_20:0|PE 20:4_20:0 (1)
-|-|-|-|-|-|-|-|-|-|-|-|-|PE 22:6_15:0|PE 22:6_15:0 (1)
-|-|-|-|-|-|-|-|-|-|-|-|P-PC P-18:0/20:4|-|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|P-PE P-16:0/20:3|-|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|PC 16:0_15:0|-|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|PC 20:1_18:0|PC 20:1_18:0|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|PC 22:6_20:2|-|- (1)
-|-|-|-|-|-|-|-|-|-|-|-|PC 22:6_20:4|-|PC 22:6_20:4 (1)
-|-|-|-|-|-|-|-|-|-|-|-|PE 19:1_16:0|-|PE 19:1_16:0 (1)
-|-|-|-|-|-|-|-|-|-|-|-|SM 19:0|-|- (1)
-|-|-|-|-|-|-|-|-|-|-|PC 18:1/20:3|-|PC 18:1/20:3|PC 18:1/20:3 (1)
-|-|-|-|-|-|-|-|-|-|-|PE 18:2_17:1|-|-|PE 18:2_17:1 (1)
-|-|-|-|-|-|-|-|-|-|-|PG 22:5_18:1|PG 22:5_18:1|PG 22:5_18:1|PG 22:5_18:1 (1)
-|-|-|-|-|-|-|-|-|-|P-PE P-18:0/18:1|-|-|-|- (1)
-|-|-|-|-|-|-|-|-|-|PC 18:1/18:1|-|-|PC 18:1/18:1|PC 18:1/18:1 (1)
-|-|-|-|-|-|-|-|-|-|PC 20:1_18:1|-|PC 20:1_18:1|PC 20:1_18:1|PC 20:1_18:1 (1)
-|-|-|-|-|-|-|-|-|-|PC 20:1_18:2|-|-|-|PC 20:1_18:2 (1)
-|-|-|-|-|-|-|-|-|-|PC 20:4_14:0|PC 20:4_14:0|PC 20:4_14:0|-|PC 20:4_14:0 (1)
-|-|-|-|-|-|-|-|-|-|PC 20:4_20:0|-|PC 20:4_20:0|-|- (1)
-|-|-|-|-|-|-|-|-|-|PC 22:5_18:1|-|PC 22:5_18:1|PC 22:5_18:1|PC 22:5_18:1 (1)
-|-|-|-|-|-|-|-|-|-|PC 24:6_16:0|-|-|PC 24:6_16:0|- (1)

Release Date

2014 (7)
2025 (6)
2024 (5)
2023 (5)
2018 (5)
2017 (5)
2021 (4)
2020 (4)
2015 (4)
2013 (4)
2022 (2)
2019 (2)
2012 (2)
2011 (2)
2026 (1)
2016 (1)
2008 (1)

Previous page
1 / 7
You're on page 1
page 2
page 3
page 4
page 5
page 6
page 7
Next page

Sort by:

Relevance

Page size

Mass Spectrometry-Based Metabolic Fingerprinting Contributes to Unveil the Role of RSUME in Renal Cell Carcinoma Cell Metabolism

Clear cell renal cell carcinoma (ccRCC) is a heterogeneous disease with 50-80% patients exhibiting mutations in the von Hippel-Lindau (VHL) gene. RSUME (RWD domain (termed after three major RWD-containing proteins: RING finger-containing proteins, WD-repeat-containing proteins, and yeast DEAD (DEXD)...

2021-10-06 | MTBLS1935 | MetaboLights

Lipid Data Analyzer: Analysis of a complex biological system from murine liver samples (Murine liver lipidome experiment)

Lipid Data Analyzer (LDA; http://genome.tugraz.at/lda2) provides automated and reliable annotation of lipid species and their molecular structures in high-throughput data from chromatography-coupled tandem mass spectrometry using embedded rule sets. Using various low- and high-resolution mass spectr...

2017-11-07 | MTBLS396 | MetaboLights

Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS

As metabolic rewiring is crucial for cancer cell proliferation, metabolic phenotyping of patient-derived organoids is desirable to identify drug-induced changes and trace metabolic vulnerabilities of tumor subtypes. We established a novel protocol for metabolomic and lipidomic profiling of colorecta...

2021-10-12 | MTBLS2130 | MetaboLights

Lipid Data Analyzer: The LDA algorithm against the in silico library LipidBlast (LipidBlast benchmarking experiment)

2017-11-07 | MTBLS397 | MetaboLights

Systematic assessment of obesity-related risk factors in renal cancer etiology: A longitudinal risk and mendelian randomization analysis.

Not available

S-EPMC12919923 | biostudies-literature

Disease-causing mutation in α-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch.

Not available

S-EPMC5816190 | biostudies-literature

Not available

S-EPMC5910831 | biostudies-literature

UBD modifies APOL1-induced kidney disease risk.